Rollins, Scott A.
University of North Carolina at Chapel Hill · Medical University of South Carolina · Universidade de São Paulo · Universidade Estadual de Campinas (UNICAMP) · East Carolina University · Augusta University · Hospital de Clínicas de Porto Alegre
2 papers on CoChatORCID 0009-0003-2658-0082
Most cited papers
- Verified
Crizanlizumab for the prevention of pain crises in sickle cell disease.
Ataga, K. I., Kutlar, A., Kanter, J., Liles, D., Cancado, R., Friedrisch, J., Guthrie, T. H., Knight-Madden, J., Alvarez, O. A., Gordeuk, V. R., et al. (2017) · New England Journal of Medicine
Hemoglobinopathies and Related DisordersBlood groups and transfusion
Cited by 914
- Verified
Discovery and Development of the Complement Inhibitor Eculizumab for the Treatment of Paroxysmal Nocturnal Hemoglobinuria
Rother, R. P., Rollins, S. A., Mojcik, C. F., Brodsky, R. A., & Bell, L. (2007) · Nature Biotechnology
Complement system in diseasesHemophilia Treatment and Research
Cited by 778
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free